chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID Vaccine Breakthrough CAse  Pfizer Dose 1 1/25/21 (lot NA) Pfizer Dose 2 2/15/21 (lot NA) Pfizer Dose 3 11/2/21 (301308A) COVID Positive 12/8/21  12/8/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who presented to the ED today due to altered mental status. She lives at facility and was noted to be confused with some low blood pressures and was sent to the ED.   Upon exam patient notes she is currently better than she was.  She notes her only pain is just below the waist. Denies any chest pain or shortness of breath.  Feels things are stuck in her esophagus.  She has a very dry mouth.  She otherwise denies headaches, nausea, abdominal pain, diarrhea, or constipation.   In the ED she was initially afebrile with a blood pressure 141/117 but then decreased to 91/55.  She was saturating 96% on room air with pulse 97. Labs are notable for sodium 132, ALP 135, lactic acid 2.2, WBC 35.13.  Urine with large leukocyte esterase, loaded bacteria, no RBCs.  Although patient asymptomatic, she did test COVID positive.  She received ceftriaxone and 2.5 L of fluid in the ED.   Surgical history:  Ileostomy, chronic G-tube, chronic suprapubic catheter  Social history:  Lives at facility  FH: Noncontributory  12/11/21: Patient is a 63 year old female with PMH multiple sclerosis, anemia, chronic osteomyelitis of the pelvis, GERD, heart failure with preserved ejection fraction, neurogenic bladder with chronic suprapubic urinary catheter, chronic G-tube, ileostomy, legally blind who had presented to the ER on 12/8/21 due to AMS and low BPs. Pt was found to have UTI with sepsis thought 2/2 indwelling suprapubic catheter. Urology was consulted and the catheter was changed out. Urine studies came back sensitive to ceftriaxone but resistant to Keflex. Given pt has allergies to Bactrim, pt will continue IM ceftriaxone 1gm for a total of 10 course given complicated UTI.  Oxybutynin was initiated by Urology which was continued on discharge.  Pt is doing well. No pain, no drainage around catheter site. Has been stable without fevers for the last few days. Will f/u with urology given renal stones in 2-3 weeks. F/U with PCP within 1-2 weeks after discharge. Holding Home Metoprolol on discharge with BP to be monitored outpatient and resumed if appropriate. Pt discharge back to facility in stable condition.
I went to give blood and they told my hemoglobin was to low to donate blood. I went to my Dr. and they told me that I developed anemia.  I am still going through this at this time.
Welts/hives near injection site, skin sensitivity from injection site and under arm with pain and itching. 05/23/05- states welts nearly resolved, hives, pain, and itching resolved. Cat bite almost healed on left hand.
vaccine given 10:25am 2-21-22.            patient felt heart racing and irritable bowel starting approximately 3:30pm 2-21-22.  she came to the pharmacy to ask about it, as she works here at the store.   blood pressure at that time 142/100mmhg which is normal  for her.   heart rate was 81 bpm.
Rigors, fever, diarrhea, symptoms have not abated currently. Pt called to report symptoms but did not come in or go to outside facility
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN ACUTE DVT, UNSPECIFIED VEIN PULMONARY EMBOLISM, UNSPECIFIED.  15/15/2021 - RECURRENCE OF SAME SYMPTOMS
FEVER WITHIN 24 OF VACCANITION DURATION 4 DAYS FOLLED BY RASH ON 5TH DAY AFTER FEVER BROKE NO (COULD NOT MAKE OUT THE HANDWRITING IN MOST OF THIS)
Narrative:  Hospice patient death with progressive lung cancer, severe lymphedema and other complications over 4 months since 2nd vaccine dose. Pfizer
Patient stated that he had trouble catching his breath the next day after receiving the first dose of Moderna Covid-19 vaccine.
PT received 1st dose Pfizer at 1100 and c/o ?itching? to arms at 1118, presenting with raised red uticaria BL to arms. PT denies any other symptoms beyond her usual baseline. HX anaphylaxis; allergies are sulfa, cats, milk and sunlight. PT denies exposure to other allergens, says this reaction does not feel like her previous anaphylactic reactions. PT reported that itchiness was worsening, spreading to back and face. PT noted to have raised red rashes to these areas as well. VS at 1128 were: SPO2 99% RA, HR 83, BP 100/64 (retaken 3 minutes later at 108/72, denies dizziness/lightheadedness, s/s hypotension). PT appeared to have no respiratory distress, reporting ?I feel good.? When asked to rate itchiness sensation, PT reported 8/10, 10 being the worst. 25 mg liquid benaryl provided PO at 1127, no facial swelling noted at this time. VS at 1138: SPO2 99% RA, HR 75. Uticaria were visibly reducing to arms, abdomen, though a slight redness was noted across cheekbones and slight swelling to eyes noted. PT continued to deny distress, symptoms except for rash. PT advised that standing orders allowed for additional doses of Benadryl, PT declined at this time, saying ?I?m fine.? PT reported itching improved to 5/10 at 1138, but levels did not improve from there. PT accepted juice and water. At 1152, PT report that itchiness was ?the same?. VS at 1155: BP 110/70, HR 64, SPO2 99% RA, RR 18. PT continued with swelling to cheeks and eyes. Education on s/s anaphylaxis/when to seek medical care was provided, PT verbalized understanding. PT was also advised to report reaction to her PCP before getting 2nd dose. At 1205, PT accepted an additional 25 mg of Benadryl PO. Uticaria to arms were resolved, improvement seen in rash to face, swelling to eyes. VS at 1215: 110/74 BP, BP 75, SPO2 98% RA. PT?s mother was on site and educated on anaphylaxis, when to seek medical care, to report events to PCP. Mother verbalized understanding. PT reported feeling well and that itchiness had improved, uticaria were resolved. PT exited facility at 1219 with mother, PT reported that she will be with family at home.
Routine Pneumovax injection given in left deltoid area 05/14.  Patient developed pain, itching, and warmth at site of injection several areas after the injection.  Ice was applied to area and IBU was prescribed for pain.
None--medication error. Pt received Dose 2 at 20 days after Dose 1. He later returned and received a Dose 3 on 5/5/21. Reported no adverse effects.
Increased muscle aches in both arms, despite receiving 1st + 2nd shots only in the same (R) arm. Difficulty lifting arms, overall body fatigue and heaviness. By 5:00pm, I had chills, enough to require a sleeping bag inside a warm home. Symptoms felt notable in that they began 5 days following my booster shot to which I had no prior adverse reaction. Symptoms disappeared within 12 hours. Following my first vaccine shot on 3/10/21 (Pfizer EN6207), I developed same-day injection-site soreness, brain fog, fatigue and a splitting headache (extremely rare) 24 hours after receiving the shot.
My daughter had the Pfizer booster vaccine on Jan 7th. She was at the end of her menstrual cycle Starting the day after the booster, her bleeding increased significantly. I took her to her primary care provider on Jan 11th. She said to get her blood work checked for her iron and hemoglobin. That afternoon she became so light headed I took her to Hospital . During the time of her ER visit her hemoglobin dropped so much that she required a blood transfusion. The ER doctor mentioned that there was some reports of the vaccine causing bleeding issues with menstrual cycles. At the hospital she was checked via ultrasound for any abnormalities such as tumors, polyps, cycts ect. Nothing was found. She has always had regular menstrual cycles up until that date. She was referred to a ob/gyn who has put her on increasing doses of birth control. She has continued to bleed (although less heavy than initial event).
Variable Fever over three days (99.8-104.2) with intermediate vomiting.  Mild rash on trunk.
Date of Admission: 4/2/2022 Chief Complaint:  Scheduled IOL Source of Information: Patient and Available medical record   History of Present Illness: This is a 30y.o. G2P1001 at 40w2d, dated by Rn. Patient seen in L&D for a scheduled IOL. Pregnancy complicated by short interval pregnancy, history of 3b laceration repair, constipation, and CF carrier.  At present (Irregular)CTX, (+) FM, (Denies) LOF, (Denies) VB.   PRENATALS: Lab Results Component Value Date   TYPE O POS 08/09/2021   GLU1HR50G 94 01/06/2022   SCRGRPBSTREP   08/11/2020     PCR result: Negative; Group B Strep DNA not detected Methodology: Nucleic Acid Amplification (FDA-approved) Culture result: Test not performed     HBSAG Nonreactive 01/06/2022   HIVSCRN Nonreactive 01/06/2022   RUBELLAABIGG 6.23 (H) 08/25/2021      Pt receives prenatal care at OB/GYN.   FHTS: 130/moderate variability/+ accelerations up to 160 lasting up to 30 seconds TOCO: q6-8 min SVE: 1+/40/-3 BSUS: Cephalic, R lateral grade 3 placenta, EFW 7# 9oz, MVP 2.73cm   BISHOP: 3 Pelvis proven to 7# 6oz with previous vaginal delivery.     Patient progressed to complete and and pushing with good maternal effort.  She delivered a viable male fetus in the ROA position.  Shoulders and body delivered without difficulty.  Cord was clamped and cut and infant was placed on patient's chest for skin to skin.  Cord blood and gases were obtained.  Placenta delivered intact and spontaneously.  Uterus explored and there was no evidence of any retained products.  Second degree laceration repaired with 3.0 vicryl.  Cervix and rectum intact.  Patient in satisfactory condition.     Antepartum complications: Short interval pregnancy, Hx of 3b perineal laceration, CF carrier, COVID 19   Primary Diagnosis: SVD (spontaneous vaginal delivery)    Hospital Course       Patient Active Problem List Diagnosis ? Blood type, Rh positive ? Rubella immune ? Short interval between pregnancies affecting pregnancy, antepartum ? History of maternal third degree perineal laceration, currently pregnant in third trimester ? Slow transit constipation ? Hemorrhoids during pregnancy in third trimester ? NST (non-stress test) reactive ? SVD (spontaneous vaginal delivery) ? Cystic fibrosis carrier ? Lactating mother   Please see the prenatal record and admission history and physical for details.   Labor Analgesics: Local     OB Complications:    Cervical Ripening Type:   Cervical Ripening Comment:      Induction: Cervidil   Induction Indications:   Augmentation:    Delivery Time: 5:13 AM  Gestational Age(weeks days/7): 40 3/7      Method of Delivery: Vaginal, Spontaneous     Birth Weight: 3.895 kg (8 lb 9.4 oz)   Sex: male   Apgar Score (1 min): 8   Apgar Score (5 min): 9     Laceration  Episiotomy: None   Laceration Type: 2nd   Perineal Laceration:      Quantified Blood Loss (ml):    Est Blood Loss      For further details of the delivery see the delivery summary.    Her post partum course was complicated by:  None     Procedures performed: SVD with repair of 2nd degree
At 4:45 pm on 9/22/23 patient received 4 vaccinations. Order of administration: 1) HPV in left deltoid; 2)Polio for travel in left deltoid; 3) meningococcal for school in right deltoid; 4) Influenza in right deltoid Immediately after receiving the influenza vaccine, patient had loss of consciousness, sweating, tingling in arms. Patient responded to name after 3-5seconds and was helped to reclining position. Offered water, cool towel, and glucose.  Patient declined water. Patient accepted cool towel and glucose.  Patient monitored for 20 minutes post-vaccination. Patient denied changes in vision, denied sob, denied chest pain, denied impairment in movement of limbs. Face and smile are symmetrical. No evidence of anaphylaxis.  After resting, and consuming glucose. Patient was release home. heart rhythm is regular. Heart rate 62 bpm. Respirations 14.
Pt developed an upper body rash. PA said it looked like MMR reaction but did not receive MMR. Mother was vague about timing and said it started a couple of days, post vax, and lasted a few days. Totally resolved now.
Extreme Eye Swelling  starting the morning after first dose lasting week one with recurrence off and on for weeks. Still happening. Another round this morning,  May 12. Skin around eyes is like a burnt layer that is peeling. No fillers or any facial cosmetic surgery ever.
Syringe Malfunctioned  after sticking needle into patient's arm. Needle separated from syringe before dose was given. All of dose was wasted. A second dose was then administered to patient per CDC guidelines.
Within 10 minutes of MMR vaccine administration patient turned very pale, started sweating. He drank some water. Did not faint. Recovered about 10 minutes later. Was observed for 30 min.
Patient presented to the ED and was subsequently hospitalized for upper and lower GI bleeding within 6 weeks of receiving COVID-19 vaccination.
10am- Rash, erythematous papular confluent rash over trunk and back 2 hours after vaccine administration.
ringing in her ears; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization. The following information was reported: TINNITUS (non-serious), outcome "unknown", described as "ringing in her ears". The event "ringing in her ears" required physician office visit. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.  Additional information: caller reported has already spoken with an ENT doctor regarding the ringing in her ears.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 25-OCT-2012 13:20, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Within 10-15 minutes after receiving Pfizer Covid Vaccination patient experienced shakiness, dizziness, difficulty breathing, wheezing, coughing, throat tightness and difficulty swallowing. Pt was given a dose of epinephrine 0.3mg and immediately patient felt her throat tightness/difficulty swallowing improve but still had shakes, wheezing, and coughing. Emergency personnel arrived and took care of patient and patient eventually went home.
She received her first dose on 12/31/20 and she stated everything was fine until 1/11/21 and she had a backache in her lower back. On 1/14/21 it was agonizing.
pt recvd vax;approx 1 hr later,itching w/ rash breaking out on arms then all over body;red,raised wheals over face,arms,hands,back,shoulders,stomach,legs & feet;c/o upper lip numb & swollen;to er,dx w/ allergic rxn to flu vax;tx DPH & corti
Acute Sialoadenitis  Inflammation of salivary glands Swollen under jaw and tongue painful Increase pain with each day  Pain move up to parotida and ear
SYMPTOMS: - COUGH STARTING THE  DAY AFTER THE INJECTION FOR ABOUT 2 WEEKS - PARESTHESIS IN LEFT ARM FOR ABOUT 3 WEEKS (PARESTHESIS IS NOT PRESENT ANYMORE) - INTTERUPTION OF MENSTRUAL CYCLE THE DAY AFTER THE SHOT (3RD DAY OF CYCLE) - MENSTRUAL CYCLE IS FORTNIGHTLY SINCE (IS STILL A  PROBLEM) - PAIN LOCALISED IN LEFT SHOULDER AND BACK (AREA: T2 - T4, LEFT RHOMBOID, LEFT SUPRASPINATUS, LEFT INFRASPIANTUS) (STARTING THE DAY AFTER THE INJECTION AND IS STILL PRESENT) - CHEST PAIN LEFT SIDE (HEART) - SEVERE ABDOMINAL PAIN IN EPIGASTRIC  & LEFT HYPOCHONDRIAL AREA (PAIN IS UNDER CONTROL WITH PENTASA TREATMENT) -  DIARRHEA (TREATED WITH ENTEROL & PENTASA)
Information has been received from a registered nurse referring to an 8 year old patient of unknown gender. There was no information about concurrent condition, concomitant medication and medical history. On 10-NOV-2016, the patient was vaccinated with a dose of GARDASIL 9 (lot # L036301, expiration date 20-DEC-2017)(dose and route unknown). No adverse effect was reported. Additional information has been requested.
Fever (101 @ highest point), chills, aching joints, sweating, fever broke at about 40 hours from injection.
Fainted - serapes on side of face, abrasions on left forehead, under left eye, corner of left nare & neck. Cut on bridge of nose & inside of upper lip.
A patient went to the emergency room and was diagnosed with acute pancreatitis one week after her second dose of GARDASIL 9; This spontaneous report was received from a physician via a company representative, referring to a 12-years-old female patient. The patient's pertinent medical history included dental surgery and seasonal allergic rhinitis. The patient's concomitant therapies included loratadine (CLARITIN) and multivitamins. Information regarding the patient's concurrent conditions and previous drug reactions was not provided.  In August 2019, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route of administration, vaccination scheme frequency, anatomical site of vaccination, lot number and expiration date were not reported) as human papillomavirus (HPV) prophylaxis. On 20-AUG-2020, the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) at a dose 0.5 milliliter (ml), administered intramuscularly in the left deltoid (lot number and expiration date were unknown by the reporter).  On 27-AUG-2020, the patient went to the emergency room (ER) for medical attention and was admitted to the hospital due to acute pancreatitis. It was reported that the patient's lipase was 3445 (no amylase was drawn) and other laboratories were unremarkable. The patient was treated with intravenous (IV) fluids and was under observation.  The outcome of pancreatitis acute was reported as recovered on 29-AUG-2020 when she was discharged from the hospital. The causal relationship between the event and therapy with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was considered unknown as there was no obvious cause for the pancreatitis acute.  Upon internal review, the event pancreatitis acute was considered to be medically significant.
a little bit sick; This spontaneous case was reported by a nurse and describes the occurrence of ILLNESS (a little bit sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (a little bit sick). At the time of the report, ILLNESS (a little bit sick) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient was not under any medication.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-438418, MOD-2022-438430 (Patient Link).
14 hours, post vax, pt had a high-pitched hysterical shrieking, which lasted 3 1/2 hours. He was very pale for 10-12 hours.
Patient stated that in the evening after her vaccine that her arm started to bother her. When she woke up the next morning her arm was red, painful and swollen. She reported this to the pharmacy and it was recommended that she see a physician. She was seen by the physician listed above in number 14.
PATIENT HAS A BLISTER THE SIZE OF QUARTER. THE PATIENT COMPLAINS ABOUT PAIN AND THE ARM IS RED/DARK BROWN
When I woke it was inflammation in most of my joints, my right hip was very sore and tender and it was hard to walk also my joints in my fingers were very tender. I was prescribed initially OTC TYLENOL.
Information has been received from a physician concerning a 66 year old female who has had "hives from something in caffeine free coke" and a reaction to an allergy shot, who on 19-DEC-2007 was vaccinated with a 0.5 mL dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included MAXIDE, PRILOSEC, ZYRTEC, NASONEX and "aspilin." On 19-DEC-2007, the patient reported that a 5 inch part of her arm turned to beet red and welts after receiving the vaccination. The patient also felt warmth and was not feeling good. Subsequently, the patient recovered about 3-4 days later. She sought unspecified medical attention. Additional information has been requested.
Weakness, fatigue, dyspnea on exertion, loss of appetite, diarrhea, sinus congestion, headaches.
Fatigue, headache, fever, chills, night sweats the first night after the vaccine. Normal temperature by morning but lymph nodes were very swollen in armpit early in the morning after the vaccine. Swelling grew worse through the day. Pain spread to ribs, below armpit, back, and underneath left breast. Started ibuprofen 400mg at noon then every 5 hours. Severe pain second night after vaccine, impacting ability to sleep. Increased ibuprofen to 600mg at 1pm that day. Started hot compresses on armpit and side. Started Benadryl 3pm that day.